The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Radical changes in multiple sclerosis pathogenesis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Fridovich (1978) · doi:10.1126/science.210504 · Cited by 3,329
Boveris, A., & Chance, B. (1973) · Biochemical Journal · doi:10.1042/bj1340707 · Cited by 2,626
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Nrf2–Keap1 defines a physiologically important stress response mechanism
Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · cited 1×
“translocates to the nucleuswhere it binds ARE and activates antioxidant enzyme gene transcription [76–78].”
BackgroundInside the Neutrophil Phagosome: Oxidants, Myeloperoxidase, and Bacterial Killing
Hampton, M. B., Kettle, A. J., & Winterbourn, C. C. (1998) · Blood · doi:10.1182/blood.v92.9.3007 · Cited by 1,652
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J. C., Smith, C. D., & Beckman, J. S. (1992) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(92)90431-u · Cited by 1,495
Regulatory Mechanisms Controlling Gene Expression Mediated by the Antioxidant Response Element
Nguyen, T., Sherratt, P. J., & Pickett, C. B. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140229 · Cited by 1,236
(2002) · PubMed · Cited by 1,190
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Mitochondrial Glutathione, a Key Survival Antioxidant
Marí, M., Morales, A., Colell, A., García-Ruiz, C., & Fernández-Checa, J. C. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2695 · Cited by 980
Multiple Sclerosis and Chronic Autoimmune Encephalomyelitis
Kornek, B., Storch, M. K., Weissert, R., Wallstroem, E., Stefferl, A., Olsson, T., Linington, C., Schmidbauer, M., & Lassmann, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64537-3 · Cited by 921
Itoh, K., Tong, K. I., & Yamamoto, M. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.075 · Cited by 864
Cadenas, E., Boveris, A., Ragan, C. I., & Stoppani, A. O. M. (1977) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(77)90035-2 · Cited by 855
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W. B., Lewis, D. A., Fox, R. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20736 · Cited by 841
Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., O'Connor, T., & Yamamoto, M. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00640.x · Cited by 816
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757 · cited 1×
“In time, patients gradually develop secondary progressive MS, which is mainly characterized by neuronal and axonal degeneration and extensive cortical demyelination [12,14,15].”
BackgroundDelivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Offen, D., Gilgun-Sherki, Y., & Melamed, E. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0348-9 · Cited by 638
Ross, D., Kepa, J. K., Winski, S. L., Beall, H. D., Anwar, A., & Siegel, D. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00199-x · Cited by 621
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
Adlam, V. J., Harrison, J. C., Porteous, C. M., James, A. M., Smith, R. A. J., Murphy, M. P., & Sammut, I. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-3718com · Cited by 618
Different Faces of the Heme-Heme Oxygenase System in Inflammation
Wagener, F. A. D. T. G., Volk, H.-D., Willis, D., Abraham, N. G., Soares, M. P., Adema, G. J., & Figdor, C. G. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.5 · Cited by 537
Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease
BEAL, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523
Redox signaling in macrophages
Jay Forman, H. (2001) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(01)00010-3 · Cited by 510
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration
Bø, L., Vedeler, C. A., Nyland, H., Trapp, B. D., & Mørk, S. J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms917oa · Cited by 478
Selective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
The double-edged role of nitric oxide in brain function and superoxide-mediated injury.
Beckman, J. S. (1991) · PubMed · Cited by 465
NAD(P)H:Quinone Oxidoreductase 1: Role as a Superoxide Scavenger
Siegel, D., Gustafson, D. L., Dehn, D. L., Han, J. Y., Boonchoong, P., Berliner, L. J., & Ross, D. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1238 · Cited by 455
Mitochondrial changes within axons in multiple sclerosis
Mahad, D. J., Ziabreva, I., Campbell, G., Lax, N., White, K., Hanson, P. S., Lassmann, H., & Turnbull, D. M. (2009) · Brain · doi:10.1093/brain/awp046 · Cited by 454
Peroxide detoxification by brain cells
Dringen, R., Pawlowski, P. G., & Hirrlinger, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20280 · Cited by 451
Craner, M. J., Newcombe, J., Black, J. A., Hartle, C., Cuzner, M. L., & Waxman, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402765101 · Cited by 446
Yang, C., Zhang, X., Fan, H., & Liu, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.009 · Cited by 443
Oxidative Stress and the Pathogenesis of Neurodegenerative Disorders
Reynolds, A., Laurie, C., Lee Mosley, R., & Gendelman, H. E. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82016-2 · Cited by 432
Regulation of genes encoding NAD(P)H:quinone oxidoreductases
Jaiswal, A. K. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00306-3 · Cited by 427
Shih, A. Y., Li, P., & Murphy, T. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4014-05.2005 · Cited by 413
Graham, D., Huynh, N. N., Hamilton, C. A., Beattie, E., Smith, R. A. J., Cochemé, H. M., Murphy, M. P., & Dominiczak, A. F. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130351 · Cited by 367
SOD, oxidative stress and human pathologies: a brief history and a future vision
McCord, J. M., & Edeas, M. A. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.03.005 · Cited by 347
Laminar Flow Induction of Antioxidant Response Element-mediated Genes in Endothelial Cells
Chen, X.-L., Varner, S. E., Rao, A. S., Grey, J. Y., Thomas, S., Cook, C. K., Wasserman, M. A., Medford, R. M., Jaiswal, A. K., & Kunsch, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m203161200 · Cited by 333
Lu, F., Selak, M., O’Connor, J., Croul, S., Lorenzana, C., Butunoi, C., & Kalman, B. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00343-9 · Cited by 331
van Horssen, J., Schreibelt, G., Drexhage, J., Hazes, T., Dijkstra, C. D., van der Valk, P., & de Vries, H. E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.023 · Cited by 318
Self-citationAktas, O., Prozorovski, T., Smorodchenko, A., Savaskan, N. E., Lauster, R., Kloetzel, P.-M., Infante-Duarte, C., Brocke, S., & Zipp, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5794 · Cited by 316
Hafler, D. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21357 · Cited by 315
Free radicals, mitochondria, and hypoxia–ischemia in the developing brain
Blomgren, K., & Hagberg, H. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.040 · Cited by 312
Expression of Inducible Nitric Oxide Synthase and Nitrotyrosine in Multiple Sclerosis Lesions
Liu, J. S.-H., Zhao, M.-L., Brosnan, C. F., & Lee, S. C. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64677-9 · Cited by 311
Heme oxygenase–1 and carbon monoxide suppress autoimmune neuroinflammation
Chora, Â. A., Fontoura, P., Cunha, A., Pais, T. F., Cardoso, S., Ho, P. P., Lee, L. Y., Sobel, R. A., Steinman, L., & Soares, M. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28844 · Cited by 306
Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS
Van Der Valk, P., & De Groot, C. J. A. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00217.x · Cited by 306
Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues
Siegel, D., & Ross, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00310-5 · Cited by 298
Baud, O., Greene, A. E., Li, J., Wang, H., Volpe, J. J., & Rosenberg, P. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3989-03.2004 · Cited by 292
Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders
Krapfenbauer, K., Engidawork, E., Cairns, N., Fountoulakis, M., & Lubec, G. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04243-9 · Cited by 287
Enhancing Expression of Nrf2-Driven Genes Protects the Blood–Brain Barrier after Brain Injury
Zhao, J., Moore, A. N., Redell, J. B., & Dash, P. K. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1683-07.2007 · Cited by 274
Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273 · cited 1×
“cerebral ischemia [132–136].”
Kim, Y.-J., Ahn, J.-Y., Liang, P., Ip, C., Zhang, Y., & Park, Y.-M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2401 · Cited by 255
Oxidative stress disrupts oligodendrocyte maturation
French, H. M., Reid, M., Mamontov, P., Simmons, R. A., & Grinspan, J. B. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22139 · Cited by 246
Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents
Zhao, J., Kobori, N., Aronowski, J., & Dash, P. K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.065 · Cited by 245
Dhanasekaran, A., Kotamraju, S., Kalivendi, S. V., Matsunaga, T., Shang, T., Keszler, A., Joseph, J., & Kalyanaraman, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404003200 · Cited by 241
Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis
Basso, A. S., Frenkel, D., Quintana, F. J., Costa-Pinto, F. A., Petrovic-Stojkovic, S., Puckett, L., Monsonego, A., Bar-Shir, A., Engel, Y., Gozin, M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33464 · Cited by 237
Enhanced number and activity of mitochondria in multiple sclerosis lesions
Witte, M. E., Bø, L., Rodenburg, R. J., Belien, J. A., Musters, R., Hazes, T., Wintjes, L. T., Smeitink, J. A., Geurts, J. J., De Vries, H. E., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2582 · Cited by 225
Self-citationNADPH oxidase as a therapeutic target in Alzheimer's disease
Block, M. L. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s8 · Cited by 204
Saretzki, G., Murphy, M. P., & Von Zglinicki, T. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00040.x · Cited by 203
Peroxynitrite formation within the central nervous system in active multiple sclerosis
Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E., & Misko, T. P. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00078-2 · Cited by 201
Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress
Juurlink, B. H. J., Thorburne, S. K., & Hertz, L. (1998) · Glia · doi:10.1002/(sici)1098-1136(199804)22:4<371::aid-glia6>3.0.co;2-6 · Cited by 196
Muthian, G., & Bright, J. J. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000040925.55682.a5 · Cited by 194
Hendriks, J. J. A., Alblas, J., van der Pol, S. M. A., van Tol, E. A. F., Dijkstra, C. D., & de Vries, H. E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040819 · Cited by 190
Self-citationWüllner, U., Seyfried, J., Groscurth, P., Beinroth, S., Winter, S., Gleichmann, M., Heneka, M., Löschmann, P.-A., Schulz, J. B., Weller, M., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01228-7 · Cited by 183
Reactive oxygen species are required for the phagocytosis of myelin by macrophages
van der Goes, A., Brouwer, J., Hoekstra, K., Roos, D., van den Berg, T. K., & Dijkstra, C. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00175-1 · Cited by 181
Gray, E., Thomas, T. L., Betmouni, S., Scolding, N., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00110.x · Cited by 175
Schreibelt, G., Musters, R. J. P., Reijerkerk, A., de Groot, L. R., van der Pol, S. M. A., Hendrikx, E. M. L., Döpp, E. D., Dijkstra, C. D., Drukarch, B., & de Vries, H. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2630 · Cited by 167
Self-citationReactive oxygen species enhance the migration of monocytes across the blood‐brain barrier in vitro
van der Goes, A., Wouters, D., van der Pol, S. M. A., Huizinga, R., Ronken, E., Adamson, P., Greenwood, J., Dijkstra, C. D., & de Vries, H. E. (2001) · The FASEB Journal · doi:10.1096/fj.00-0881fje · Cited by 162
Self-citationNew perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases
Deby, C., & Goutier, R. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90043-k · Cited by 160
Kean, R. B., Spitsin, S. V., Mikheeva, T., Scott, G. S., & Hooper, D. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6511 · Cited by 157
Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease
Perry, G. L., Moreira, P. I., Santos, M. S., Oliveira, C. R., Shenk, J. C., Nunomura, A., Smith, M. A., & Zhu, X. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708783885156 · Cited by 155
Ruuls, S. R., Bauer, J., Sontrop, K., Huitinga, I., Hart, B. A. ‘., & Dijkstra, C. D. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(94)00154-g · Cited by 153
Grey matter pathology in multiple sclerosis
Bø, L., Geurts, J. J. G., Mörk, S., & van der Valk, P. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00615.x · Cited by 151
Ferretti, G., Bacchetti, T., Principi, F., DiLudovico, F., Viti, B., Angeleri, V. A., Danni, M. C., & Provinciali, L. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1240oa · Cited by 149
Sulforaphane improves cognitive function administered following traumatic brain injury
Dash, P. K., Zhao, J., Orsi, S. A., Zhang, M., & Moore, A. N. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.028 · Cited by 148
Butts, B. D., Houde, C., & Mehmet, H. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.70 · Cited by 146
Tajouri, L., Mellick, A. S., Ashton, K. J., Tannenberg, A. E. G., Nagra, R. M., Tourtellotte, W. W., & Griffiths, L. R. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.09.008 · Cited by 143
Qi, X., Lewin, A. S., Sun, L., Hauswirth, W. W., & Guy, J. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603717200 · Cited by 142
Bizzozero, O. A., DeJesus, G., Callahan, K., & Pastuszyn, A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20587 · Cited by 134
Mitochondrial peroxiredoxin‐3 protects hippocampal neurons from excitotoxic injury in vivo
Hattori, F., Murayama, N., Noshita, T., & Oikawa, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01918.x · Cited by 133
Liu, Y., Zhu, B., Wang, X., Luo, L., Li, P., Paty, D. W., & Cynader, M. S. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00132-2 · Cited by 133
Hung, S., Liou, H., Kang, K., Wu, R., Wen, C.-C., & Fu, W. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048611 · Cited by 133
Mehindate, K., Sahlas, D. J., Frankel, D., Mawal, Y., Liberman, A., Corcos, J., Dion, S., & Schipper, H. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00354.x · Cited by 129
Elevated myeloperoxidase activity in white matter in multiple sclerosis
Gray, E., Thomas, T. L., Betmouni, S., Scolding, N. J., & Love, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.035 · Cited by 127
Qi, X., Lewin, A. S., Sun, L., Hauswirth, W. W., & Guy, J. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0553 · Cited by 126
Differential expression of peroxiredoxin subtypes in human brain cell types
Sarafian, T. A., Verity, M. A., Vinters, H. V., Shih, C. C.-Y., Shi, L., Ji, X. D., Dong, L., & Shau, H. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990415)56:2<206::aid-jnr10>3.0.co;2-x · Cited by 124
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells
Wierinckx, A., Brevé, J. J. P., Mercier, D., Schultzberg, M., Drukarch, B., & van Dam, A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.013 · Cited by 122
Chen, K., Thomas, S. R., Albano, A., Murphy, M. P., & Keaney, J. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404859200 · Cited by 117
İlhan, A., Akyol, Ö., Gürel, A., Armutçu, F., Iraz, M., & Öztaş, E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.022 · Cited by 116
Microglia, an in vivo source of reactive oxygen species in the brain.
Colton, C. A., & Gilbert, D. L. (1993) · PubMed · Cited by 113
Emerging roles of thioredoxin cycle enzymes in the central nervous system
Patenaude, A., Murthy, M. R. V., & Mirault, M.-É. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4541-5 · Cited by 112
Peroxynitrite-mediated lipid oxidation and nitration: mechanisms and consequences
Rubbo, H., Trostchansky, A., & O’Donnell, V. B. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.11.007 · Cited by 105 · cited 1×
“Nitric oxide reacts with superoxide to form highly toxic peroxynitrite, which in turn might attack tyrosine residues of proteins, thereby affecting their function [22].”
BackgroundAntioxidants and polyunsaturated fatty acids in multiple sclerosis
van Meeteren, M. E., Teunissen, C. E., Dijkstra, C. D., & van Tol, E. A. F. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602255 · Cited by 105
Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis
Liu, Y., Zhu, B., Luo, L., Li, P., Paty, D. W., & Cynader, M. S. (2001) · Neuroreport · doi:10.1097/00001756-200107030-00016 · Cited by 103
The involvement of mitochondria in the pathogenesis of multiple sclerosis
Kálmán, B., Laitinen, K., & Komoly, S. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.03.020 · Cited by 97
Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis
Greco, A., Minghetti, L., Sette, G., Fieschi, C., & Levi, G. (1999) · Neurology · doi:10.1212/wnl.53.8.1876 · Cited by 97
Chaudhary, P., Marracci, G., & BOURDETTE, D. N. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.007 · Cited by 96
Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice
Plaisant, F., Clippe, A., Stricht, D. V., Knoops, B., & Gressèns, P. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01440-5 · Cited by 94
Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis
Andrews, H., Nichols, P. P., Bates, D., & Turnbull, D. M. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.09.001 · Cited by 93
Distribution of dt diaphorase in the rat brain: Biochemical and immunohistochemical studies
Schultzberg, M., Segura-Aouilar, J., & Lind, C. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90181-9 · Cited by 88
Koch, M. W., Ramsaransing, G. S. M., Arutjunyan, A. V., Stepanov, M., Teelken, A. W., Heersema, D. J., & Keyser, J. D. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0037-3 · Cited by 86
Stahnke, T., Richter‐Landsberg, C., Stadelmann, C., Netzler, A., & Brück, W. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0005-8 · Cited by 86
Protein co-expression with axonal injury in multiple sclerosis plaques
Diaz-Sanchez, M., Williams, K., DeLuca, G. C., & Esiri, M. M. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0045-0 · Cited by 85
Glial nitric oxide and ischemia
Gibson, C. L., Coughlan, T. C., & Murphy, S. P. (2005) · Glia · doi:10.1002/glia.20143 · Cited by 84
Mitochondrial Glutathione: A Modulator of Brain Cell Death
Sims, N. R., Nilsson, M., & Muyderman, H. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041763.63958.e7 · Cited by 81
Mitochondrial DNA mutations in multiple sclerosis
Kálmán, B., Fd, L., & Alder, H. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100106 · Cited by 79
Kálmán, B., Li, S., Chatterjee, D., O'Connor, J., Voehl, M. R., Brown, M. D., & Alder, H. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00653.x · Cited by 79
Antioxidants in Multiple Sclerosis: Do They Have a Role in Therapy?
Carlson, N. G., & ROSE, J. W. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00001 · Cited by 75
Siler‐Marsiglio, K. I., Pan, Q., Paiva, M., Madorsky, I., Khurana, N. C., & Heaton, M. B. (2005) · Brain Research · doi:10.1016/j.brainres.2005.06.030 · Cited by 75
Olsen, N. K., Hansen, A. W., Nørby, S., Edal, A. L., Jørgensen, J. R., & Rosenberg, T. (1995) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb07016.x · Cited by 75
Nonenzymatic antioxidants of blood in multiple sclerosis
Karg, E., Klivènyi, P., Németh, I., Bencsik, K., Pintér, S., & Vécsei, L. (1999) · Journal of Neurology · doi:10.1007/s004150050399 · Cited by 72
NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions
van Horssen, J., Schreibelt, G., Bø, L., Montagne, L., Drukarch, B., Muiswinkel, F. L. V., & de Vries, H. E. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.04.013 · Cited by 71
Self-citationGuy, J. R., Qi, X., & Hauswirth, W. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13847 · Cited by 71
Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis
Waxman, S. G. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.03.001 · Cited by 70
Calabrese, V., Raffaele, R., Cosentino, E. R., & Rizza, V. (1994) · PubMed · Cited by 68
Liu, Y., Liu, J., Tetzlaff, W., Paty, D. W., & Cynader, M. S. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.07.021 · Cited by 67
Chen, X., Dodd, G. L., & KUNSCH, C. A. (2009) · Inflammation Research · doi:10.1007/s00011-009-0017-7 · Cited by 63
Hemeoxygenase-1 in SJL mice with experimental allergic encephalomyelitis
Chakrabarty, A., Emerson, M. R., & LeVine, S. M. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms928oa · Cited by 60
Emerson, M. R., & LeVine, S. M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752555.x · Cited by 57
Karunakaran, S., Saeed, U., Ramakrishnan, S., Koumar, R. C., & Ravindranath, V. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.019 · Cited by 51
Characterization of the mitochondrial DNA in patients with multiple sclerosis
Kálmán, B., LUBLIN, F. D., & Alder, H. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00112-8 · Cited by 45
Evidence of Nitrosative Damage in the Brain White Matter of Patients with Multiple Sclerosis
Bizzozero, O. A., DeJesus, G., Bixler, H. A., & Pastuszyn, A. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9695-2 · Cited by 43
Protective effects of peroxiredoxin-1 at the injured blood–brain barrier
Schreibelt, G., van Horssen, J., Haseloff, R. F., Reijerkerk, A., van der Pol, S. M. A., Nieuwenhuizen, O. F. M., Krause, E., Blasig, I. E., Dijkstra, C. D., Ronken, E., et al. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.024 · Cited by 40
Self-citationIs the mitochondrial DNA involved in determining susceptibility to multiple sclerosis?
Kálmán, B., & Alden, H. (1998) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb07301.x · Cited by 38
Antioxidant enzyme suppression of demyelination in experimental optic neuritis
Guy, J. R., Ellis, E. A., Hope, G. M., & Rao, N. A. (1989) · Current Eye Research · doi:10.3109/02713688909000027 · Cited by 37
Covey, M. V., Murphy, M. P., Hobbs, C., Smith, R. A. J., & Oorschot, D. E. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.026 · Cited by 36
Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes
Holley, J. E., Newcombe, J., Winyard, P. G., & Gutowski, N. J. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507078064 · Cited by 35
Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis
Moriya, M., Nakatsuji, Y., Miyamoto, K., Okuno, T., Kinoshita, M., Kumanogoh, A., Kusunoki, S., & Sakoda, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.110 · Cited by 34
Antioxidant Enzymes Reduce Loss of Blood-Brain Barrier Integrity in Experimental Optic Neuritis
Guy, J. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020429048 · Cited by 34
Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis.
Qi, X., Guy, J. R., Nick, H. S., Valentine, J., & Rao, N. A. (1997) · PubMed · Cited by 31
Iron Regulation in the Brain at the Cell and Molecular Level
Connor, J. R. (1994) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-2554-7_25 · Cited by 31
Adenoviral Gene Therapy With Catalase Suppresses Experimental Optic Neuritis
Guy, J. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.11.1533 · Cited by 29
Gilgun‐Sherki, Y., Barhum, Y., Atlas, D., Melamed, E., & Offen, D. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:125 · Cited by 24
Possible Protective Mechanisms of Heme Oxygenase‐1 in the Brain
Takata, K., Kitamura, Y.-I., Kakimura, J., Shibagaki, K., Taniguchi, T., Gebicke‐Haerter, P. J., Smith, M. A., Perry, G. L., & Shimohama, S. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04857.x · Cited by 12
Cited by
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Oxidative damage in multiple sclerosis lesions
Haider, L., Fischer, M. T., Frischer, J. M., Bauer, J., Hoftberger, R., Botond, G., Esterbauer, H., Binder, C. J., Witztum, J. L., & Lassmann, H. (2011) · Brain · doi:10.1093/brain/awr128 · Cited by 753
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Buendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Metadata
- Authors
- van Horssen, J., Witte, M. E., Schreibelt, G., & de Vries, H. E.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 1812
- Issue
- 2
- Pages
- 141-150
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2076058447
- Cited by
- 322
- References
- 139
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.